Skip to main content

Advertisement

SpringerLink
Log in

Neues zur Gicht

Informationen vom ACR-Kongress 2017

New aspects on gout

Information from the ACR conference 2017

  • Hot topics
  • Published:
Zeitschrift für Rheumatologie Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Merriman TR et al (2017) A genome-wide association study of gout in people of European ancestry. 2017 ACR/ARHP Annual Meeting. S Abstract 1104

    Google Scholar 

  2. Kapetanovic MC et al (2017) The absolute risk of clinically diagnosed gout by serum uric acid levels – results from 30 years follow-up of the Malmö preventive project cohort in southern Sweden. ACR, S Abstract 1117

    Google Scholar 

  3. Pascart T et al (2017) Patients with early onset gout develop earlier severe joint involvement and metabolic comorbid conditions. ACR, S Abstract 2084

    Google Scholar 

  4. Neogi T et al (2015) Gout classification criteria: an American College of Rheumatology/ European League Against Rheumatism collaborative initiative. Ann Rheum Dis 74(10):1789–1798

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Chinchilla S et al (2017) Are we ready ? Changes in the profile of gout patients over the last 25 years. ACR, S Abstract 1133

    Google Scholar 

  6. Andrés M et al (2017) Gout characteristics and its association with the presence of cardiovascular disease: a case-control study. ACR, S Abstract 1140

    Google Scholar 

  7. Kachur P et al (2017) Associations between gout and cancer in an NHanes cohort. ACR, S Abstract 1146

    Google Scholar 

  8. Gaffo AL et al (2017) Validation of a definition for flare in patients with established gout. ACR, S Abstract 2950

    Google Scholar 

  9. Schlesinger N (2017) Evidence-based development of criteria for complete response in patients with chronic refractory gout. ACR, S Abstract 2070

    Google Scholar 

  10. Wang P et al (2017) Identification of urate deposits in patients with asymptomatic hyperuricemia using a dual-energy CT scan. ACR, S Abstract 2057

    Google Scholar 

  11. Vargas-Santos AB et al (2017) Relation of serum urate and gout duration to tophi, urate deposition, and inflammation. ACR, S Abstract 2063

    Google Scholar 

  12. Stamp LK, O’Donnell JL, Zhang M et al (2011) Using allopurinol above the dose based on creatinine clearance is effective and safe in patients with chronic gout, including those with renal impairment. Arthritis Rheum 63:412–421

    Article  CAS  PubMed  Google Scholar 

  13. Stamp LK et al (2017) Allopurinol dose escalation to achieve serum urate below 6 mg/Dl: an open label extension study. ACR, S Abstract 1105

    Google Scholar 

  14. Lim JJ et al (2017) Allopurinol Treatment for Gout: How Long to Reach Serum Urate Goal? ACR, S Abstract 1121

    Google Scholar 

  15. Kiltz U, Smolen J, Bardin T, Cohen Solal A, Dalbeth N, Doherty M, Engel B, Flader C, Kay J, Matsuoka M, Perez-Ruiz F, da Rocha Castelar-Pinheiro G, Saag K, So A, Vazquez Mellado J, Weisman M, Westhoff TH, Yamanaka H, Braun J (2017) Treat-to-target (T2T) recommendations for gout. Ann Rheum Dis 76(4):632–638

    Article  CAS  PubMed  Google Scholar 

  16. Kiltz U, Alten R, Fleck M, Krüger K, Manger B, Müller-Ladner U, Nüsslein H, Reuss-Borst M, Schwarting A, Schulze-Koops H, Tausche AK, Braun J (2017) Evidence-based recommendations for diagnostics and treatment of gouty arthritis in the specialist sector : S2e guidelines of the German Society of Rheumatology in cooperation with the AWMF. Z Rheumatol 76(2):118–124

    Article  CAS  PubMed  Google Scholar 

  17. Morlock R et al (2017) Less than half of patients treated with high-dose allopurinol reach serum uric acid target. ACR, S Abstract 1120

    Google Scholar 

  18. Zhang MA et al (2017) Risk of cardiovascular events in older patients with gout initiating febuxostat versus allopurinol: a population-based cohort study. ACR, S Abstract 2844

    Google Scholar 

  19. Singh JA, Cleveland JD (2017) Comparative effectiveness of allopurinol versus febuxostat for preventing incident renal disease in older adults: an analysis of Medicare claims data. Ann Rheum Dis 76(10):1669–1678

    Article  PubMed  Google Scholar 

  20. Kachur P et al (2017) Hydration and gout: looking at new modes of uric acid management. ACR, S Abstract 2989

    Google Scholar 

  21. Ostrowski RA et al (2017) Efficacy of high dose versus moderate dose of prednisone in the treatment of acute gout. ACR, S Abstract 1112

    Google Scholar 

  22. Sharma E, Terkeltaub R (2017) A case control study of anakinra use for acute gout in a VA patient cohort reveals association with east asian descent, high urate burden, and increased co-morbidities and all-cause mortality. ACR, S Abstract 1142

    Google Scholar 

  23. Desmarais J, Cong-Qiu C (2017) Utility of anakinra in acute crystalline diseases: a retrospective study comparing a university hospital with veterans affairs medical center. ACR, S Abstract 2090

    Google Scholar 

  24. Mandell BF et al (2017) Rapid tophus resolution in chronic refractory gout patients treated with pegloticase. ACR, S Abstract 2054

    Google Scholar 

  25. McWherter C et al (2017) Arhalofenate acid inhibits urate crystal-induced inflammatory responses through activation of AMP-activated protein Kinase (AMPK) signaling. ACR, S Abstract 2089

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Rheumazentrum Ruhrgebiet, Claudiusstr. 45, 44649 , Herne, Deutschland

    J. Braun &  U. Kiltz

Authors
  1. J. Braun
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. U. Kiltz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J. Braun.

Ethics declarations

Interessenkonflikt

J. Braun und U. Kiltz geben an, dass kein Interessenkonflikt besteht.

Additional information

Redaktion

U. Müller-Ladner, Bad Nauheim

U. Lange, Bad Nauheim

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Braun, J., Kiltz, U. Neues zur Gicht. Z Rheumatol 77, 1–6 (2018). https://doi.org/10.1007/s00393-017-0414-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00393-017-0414-1

Search

Navigation